Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-012065
Filing Date
2015-08-13
Accepted
2015-08-13 08:34:17
Documents
2
Period of Report
2015-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3557
2 LIMITED POWER OF ATTORNEY limitedpowerofattorney.txt EX-24 4224
  Complete submission text file 0001179110-15-012065.txt   9187
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Dineen John M. (Reporting) CIK: 0001645270 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35409 | Film No.: 151048808